Drug details
Cyltezo (adalimumab-adbm injection, for subcutaneous use)
type of DMARDs, TNF Inhibitors
Cyltezo (adalimumab-adbm injection) is a tumor necrosis factor (TNF) blocker indicated for treatment of:
The following drugs are related to Cyltezo, either as a replacement or used together:
- Humira (adalimumab injection solution for subcutaneous administration)
- Celebrex (celecoxib)
- Duobrii (halobetasol propionate and tazarotene lotion)
- Enbrel (etanercept)
- Myochrysine (gold sodium thiomalate)
- Remicade (infliximab)
- Vtama (tapinarof cream)